The science behind Balance Complex.

1. [1] Hallen A, Jarstrand C, Pahlson C (1992). Treatment of bacterial vaginosis with lactobacilli. Sexually Transmitted Diseases. PMID 1523530.

   Ingredient: L. acidophilus

   57% of women treated with L. acidophilus had normal vaginal flora restored vs 0% placebo.

2. [2] Reznichenko H, et al. (2020). Oral Intake of Lactobacilli Can Be Helpful in Symptomatic Bacterial Vaginosis: A Randomized Clinical Study. Journal of Lower Genital Tract Disease. PMID 32091443.

   Ingredient: L. acidophilus (combo)

   BV recurrence 18.3% vs 32.1% placebo (p=.014) in 166-woman trial.

3. [3] Reid G, et al. (2003). Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora. FEMS Immunology & Medical Microbiology. PMID 12628548.

   Ingredient: L. rhamnosus

   37% on probiotics restored normal flora vs 13% placebo over 60 days.

4. [4] Cianci A, et al. (2008). Efficacy of L. rhamnosus GR-1 and L. reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses. Minerva Ginecologica. PMID 18854803.

   Ingredient: L. rhamnosus + L. reuteri

   92% of patients achieved complete Lactobacilli recolonization.

5. [5] Ansari A, et al. (2023). Lactobacillus Probiotics Improve Vaginal Dysbiosis in Asymptomatic Women. Nutrients. PMID 37111086.

   Ingredient: L. acidophilus + L. rhamnosus + L. reuteri

   60% of women with high Nugent scores improved to healthy after 6 weeks oral probiotic.

6. [6] Kohler GA, et al. (2012). Probiotic interference of L. rhamnosus GR-1 and L. reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infectious Diseases in Obstetrics & Gynecology. PMID 22811591.

   Ingredient: L. rhamnosus + L. reuteri vs Candida

   Lactic acid suppressed C. albicans growth; reduced fluconazole-resistance gene expression (in vitro).

7. [7] De Seta F, et al. (2014). Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. European Journal of Obstetrics, Gynecology and Reproductive Biology. PMID 25305660.

   Ingredient: L. plantarum

   L. plantarum increased vaginal Lactobacillus levels in 89-woman 3-month study.

8. [8] De Seta F, et al. (2024). Efficacy and safety of Lactobacillus plantarum P 17630 strain soft vaginal capsules compared to antifungal treatment. Journal of Lower Genital Tract Disease. PMID 38235890.

   Ingredient: L. plantarum vs antifungal

   L. plantarum non-inferior to standard antifungal for vaginal candidiasis.

9. [9] Spaggiari L, et al. (2024). Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro. Microorganisms. PMID 39203476.

   Ingredient: B. coagulans vs Candida

   B. coagulans impaired Candida virulence and protected vaginal epithelium (in vitro).

10. [10] Tsimaris P, et al. (2020). Alleviation of vulvovaginitis symptoms: can probiotics lead the treatment plan?. Beneficial Microbes. PMID 31965832.

    Ingredient: B. coagulans

    Significant reduction in vaginal pH + alleviation of vulvovaginal discomfort symptoms (p<0.001) in 70-woman trial.

11. [11] Williams G, et al. (2023). Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. PMID 37068952.

    Ingredient: Cranberry

    Cochrane Review of 50 studies (N=8,857) — cranberry products reduce UTI risk in women with recurrent UTIs.

12. [12] Luís Â, et al. (2017). Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women. Journal of Nutrition. PMID 29046404.

    Ingredient: Cranberry

    Cranberry effective in preventing UTI recurrence in healthy women.

13. [13] Terlizzi N, et al. (2024). Preventive effect of cranberries with high dose of proanthocyanidins on UTI: a meta-analysis. Meta-analysis. PMID 39668896.

    Ingredient: Cranberry PAC dose

    Higher proanthocyanidin doses correlate with stronger UTI prevention effect.

14. [14] Kranjcec B, et al. (2014). D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology. PMID 23633128.

    Ingredient: D-Mannose

    Recurrence dropped from 60.8% (no prophylaxis) to 14.6% on D-mannose, comparable to nitrofurantoin (20.4%) — N=308.

15. [15] Lenger SM, et al. (2020). D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology. PMID 32497610.

    Ingredient: D-Mannose

    D-mannose appears protective vs placebo; possibly similar effectiveness as antibiotics.

16. [16] Jadhav A, et al. (2017). The Dietary Food Components Capric Acid and Caprylic Acid Inhibit Virulence Factors in Candida albicans Through Multitargeting. Journal of Medicinal Food. PMID 28922057.

    Ingredient: Caprylic acid vs Candida

    Caprylic acid inhibits morphogenesis, adhesion, biofilm formation, and arrests Candida cell cycle.

17. [17] Kim SH, et al. (2007). Inhibition of Candida mycelia growth by caprylic acid and capric acid. Journal of Microbiology & Biotechnology. PMID 23257726.

    Ingredient: Caprylic acid antifungal

    Caprylic acid inhibits Candida mycelia growth at low concentrations.

18. [18] Kim SH, et al. (2019). Short-Term Antifungal Treatments of Caprylic Acid with Carvacrol or Thymol Synergistically Inhibit Candida albicans. mSphere. PMID 31334617.

    Ingredient: Caprylic + carvacrol synergy

    Caprylic acid + carvacrol show synergistic antifungal effect — Balance Complex uniquely combines both.

19. [19] Chami F, et al. (2004). Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. Journal of Antimicrobial Chemotherapy. PMID 15456732.

    Ingredient: Carvacrol (oregano) vaginal

    Carvacrol eradicated vaginal fungal burden in 7/9 rats (prophylactic in vivo).

20. [20] Kelly GS (1999). Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Alternative Medicine Review. PMID 10231609.

    Ingredient: Arabinogalactan

    Arabinogalactan enhances Lactobacillus + Bifidobacteria; FDA-approved dietary fiber.

21. [21] Henao SLD, et al. (2018). Randomized Clinical Trial for the Evaluation of Immune Modulation by β-Glucans from Ganoderma lucidum. International Journal of Medicinal Mushrooms. PMID 30317947.

    Ingredient: Reishi (Ganoderma lucidum)

    Significantly increased peripheral blood lymphocyte counts vs placebo (RCT).

Two additional supporting references (Aloe vera + Black walnut hulls) are cited as “in published research” in the formula breakdown without a specific PMID — full bibliography entries pending vault verification. The locked “23 studies” figure on the homepage counts those two pending entries.